Search results
Only 28 years old, Weymouth woman already beat ovarian cancer once
WFXT via Yahoo News· 6 hours agoO’Hear’s cancer was Stage 3C — meaning it had metastasized to nearby organs. But developing it at age 25? How to explain that? “It’s a rare subtype of ovarian cancer ...
Is that mole melanoma? How to tell if a mole is cancerous or not
TODAY via Yahoo News· 2 days agoEarly detection is critical. The Skin Cancer Foundation recommends an annual skin exam by a...
Many Patients With Advanced MCC Not Receiving Immunotherapy
Medscape· 3 days agoDespite improved survival rates and guideline recommendations, many eligible patients with...
YOUR HEALTH: Rare skin cancer that killed Jimmy Buffett
WAFB Baton Rouge· 7 days agocancer connected to the neuroendocrine system through nerve endings in the skin. Singer Jimmy...
Outsmarting Ovarian Cancer
The Scientist· 24 hours agoWhile Stack’s early biochemistry studies were not in the cancer field, losing a family member to the disease refocused her research interest and...
Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy study - Maryland...
The Daily Record· 10 hours agoThe project will study the drug’s effectiveness in newly diagnosed advanced primary head and neck cancer patients with no lymph node involvement, determined via PET scan, ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
The Journal Times· 6 days ago"The high complete response rate and durability of these responses observed in patients treated with...
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD...
FOX 23 News Albany· 2 days agoAnother...Another comparison of BLC with Hexvix®/Cysview® and white light cystoscopy (WLC), for the...
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 1 day agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published ...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
FOX 4 Kansas City· 3 days agoResults featured updated data from Cohort 1 (C1), patients with recurrent, Bacillus Calmette-Guérin...
